Orkla India Limited has approved the grant of 11,11,850 employee stock options under its Employee Stock Option Plan 2025 (ESOP 2025). The grant was made by the Nomination and Remuneration Committee to eligible employees. The exercise price for these options is set at ₹702.90 per option. The options are exercisable into fully paid-up equity shares of the company and are subject to vesting conditions.
Orkla India Approves Employee Stock Options
Orkla India Limited has announced the approval of employee stock options under its established Employee Stock Option Plan 2025 (ESOP 2025). The decision, made via a circular resolution by the Nomination and Remuneration Committee on November 5, 2026, will see 11,11,850 employee stock options (referred to as “Options”) granted to eligible employees.
Key Grant Details
The grant aligns with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The exercise price for each Option has been fixed at ₹702.90. This pricing is based on the closing market price of the company’s equity shares on the NSE on November 4, 2026, and an approved pricing methodology detailed within the ESOP 2025 plan.
Each granted Option entitles the holder to one fully paid-up equity share of Orkla India Limited, subject to potential adjustments as per the ESOP 2025 terms. The Options will have a fixed vesting period of three years from the grant date, with a minimum vesting period of one year, contingent upon continued employment and satisfaction of specified conditions.
Information Disclosure
Details regarding the grant, including the number of options, pricing formula, vesting period, and exercise terms, have been made available on the company’s website at https://www.orklaindia.com/investor-relations/. The company has provided this intimation as per the requirements under Regulation 30 of the SEBI Listing Regulations.
Source: BSE
